Oxygenta [OXYGENTAPH] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Oxygenta Pharmaceutical Ltd.

BSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Oxygenta Pharmaceutical Ltd. wins in 4 metrics, Innova Captab Ltd. wins in 14 metrics, with 0 ties. Innova Captab Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Oxygenta Pharmaceutical Ltd. Innova Captab Ltd. Better
P/E Ratio (TTM) 444.32 31.20 Innova Captab Ltd.
Price-to-Book Ratio -5.50 4.05 Innova Captab Ltd.
Debt-to-Equity Ratio -1.99 32.95 Innova Captab Ltd.
PEG Ratio 19.02 1.33 Innova Captab Ltd.
EV/EBITDA -15.15 20.49 Innova Captab Ltd.
Profit Margin (TTM) -15.47% 8.85% Innova Captab Ltd.
Operating Margin (TTM) -14.55% 12.88% Innova Captab Ltd.
EBITDA Margin (TTM) N/A 12.88% N/A
Return on Equity 38.69% 13.37% Oxygenta Pharmaceutical Ltd.
Return on Assets (TTM) -11.61% 8.12% Innova Captab Ltd.
Free Cash Flow (TTM) $-87.89M $-1.09B Oxygenta Pharmaceutical Ltd.
Dividend Yield N/A 0.30% N/A
1-Year Return -45.31% -3.19% Innova Captab Ltd.
Price-to-Sales Ratio (TTM) 1.87 2.76 Oxygenta Pharmaceutical Ltd.
Enterprise Value $2.82B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 2.50 2.90 Oxygenta Pharmaceutical Ltd.
Gross Profit Margin (TTM) -4.06% 35.19% Innova Captab Ltd.
Revenue per Share (TTM) $31 $262 Innova Captab Ltd.
Earnings per Share (Diluted) $-4.72 $23.16 Innova Captab Ltd.
Beta (Stock Volatility) 0.52 -0.33 Innova Captab Ltd.

Oxygenta Pharmaceutical Ltd. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

OXYGENTAPH
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Oxygenta Pharmaceutical Ltd.1.71%-5.41%-12.37%-0.30%-20.06%-7.05%
Innova Captab Ltd.1.81%1.28%1.49%32.44%19.52%16.05%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Oxygenta Pharmaceutical Ltd.-45.31%60.31%375.14%380.79%624.83%225.39%
Innova Captab Ltd.-3.19%57.07%57.07%57.07%57.07%57.07%

Performance & Financial Health Analysis: Oxygenta Pharmaceutical Ltd. vs Innova Captab Ltd.

MetricOXYGENTAPHINNOVACAP
Market Information
Market Cap i₹2.00B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i5,432578,151
90 Day Avg. Volume i7,995217,693
Last Close₹50.70₹872.55
52 Week Range₹45.30 - ₹133.50₹622.00 - ₹1,020.70
% from 52W High-62.02%-14.51%
All-Time High₹133.50 (Jun 09, 2025)₹1,260.00 (Jan 06, 2025)
% from All-Time High-62.02%-30.75%
Growth Metrics
Quarterly Revenue Growth0.02%0.42%
Quarterly Earnings GrowthN/A0.23%
Financial Health
Profit Margin (TTM) i-0.15%0.09%
Operating Margin (TTM) i-0.15%0.13%
Return on Equity (TTM) i0.39%0.13%
Debt to Equity (MRQ) i-1.9932.95
Cash & Liquidity
Book Value per Share (MRQ)₹-9.89₹178.28
Cash per Share (MRQ)₹0.34₹10.22
Operating Cash Flow (TTM) i₹-61,057,000₹282.88M
Levered Free Cash Flow (TTM) i₹-96,826,000₹1.28B
Dividends
Last 12-Month Dividend Yield iN/A0.30%
Last 12-Month Dividend iN/A₹2.00

Valuation & Enterprise Metrics Analysis: Oxygenta Pharmaceutical Ltd. vs Innova Captab Ltd.

MetricOXYGENTAPH (Apr 24, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i444.3231.20
Forward P/E iN/A21.90
PEG Ratio i19.021.33
Price to Sales (TTM) i1.872.76
Price to Book (MRQ) i-5.504.05
Market Capitalization
Market Capitalization i₹2.00B₹41.43B
Enterprise Value i₹2.82B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i2.502.90
Enterprise to EBITDA i-15.1520.49
Risk & Other Metrics
Beta i0.52-0.33
Book Value per Share (MRQ) i₹-9.89₹178.28

Financial Statements Comparison: Oxygenta Pharmaceutical Ltd. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricOXYGENTAPH (2025)INNOVACAP (2025)
Revenue/Sales i1.09B12.34B
Cost of Goods Sold i1.08B8.38B
COGS % of Revenue i98.5%67.9%
Gross Profit i16.68M3.96B
Gross Margin i1.5%32.1%
Research & Development iN/AN/A
Operating Income (EBIT) i-103.50M1.65B
Operating Margin i-9.5%13.4%
EBITDA i-84.49M2.00B
EBITDA Margin i-7.7%16.2%
Pre-Tax Income i-115.53M1.71B
Pre-Tax Income % of Revenue i-10.6%13.9%
Income Tax i-18.70M427.58M
Income Tax % of Revenue i-1.7%3.5%
Net Income (Profit) i-96.83M1.28B
Profit Margin i-8.9%10.4%

Balance Sheet & Liquidity Metrics

MetricOXYGENTAPH (2025)INNOVACAP (2025)
Cash & Equivalents i17,000155.19M
Total Current Assets i309.43M7.03B
Total Current Assets % of Revenue i28.3%57.0%
Total Current Liabilities i858.47M3.53B
Total Current Liabilities % of Revenue i78.5%28.6%
Long-Term Debt i215.22M2.45B
Long-Term Debt % of Revenue i19.7%19.8%
Total Shareholders Equity i-250.25M9.59B
Retained Earnings i-735.63M4.53B
Retained Earnings % of Revenue i-67.3%36.7%
Property, Plant & Equipment i14.36M442.93M

Cash Flow Statement Comparison

MetricOXYGENTAPH (2025)INNOVACAP (2025)
Operating Cash Flow i-61.06M282.88M
Operating Cash Flow % of Revenue i-5.6%2.3%
Capital Expenditures i-112.72M-1.72B
Free Cash Flow i-87.89M-1.09B
FCF Margin i-8.0%-8.8%
Debt Repayment iN/A-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricOXYGENTAPHINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i36.98M57.22M
Float Shares i4.87M15.91M
% Held by Insiders i81.94%72.19%
% Held by Institutions i0.00%19.22%
% Held by Public i18.06%8.59%

Dividend Analysis & Yield Comparison: Oxygenta Pharmaceutical Ltd. vs Innova Captab Ltd.

MetricOXYGENTAPHINNOVACAP
Last 12-Month Dividend iN/A₹2.00
Last 12-Month Dividend Yield iN/A0.30%
3-Year Avg Annual Dividend iN/A₹0.67
3-Year Avg Dividend Yield iN/A0.30%
3-Year Total Dividends iN/A₹2.00
Ex-Dividend DateN/AJan 30, 2026